Citigroup Portfolio holdings
Citigroup is a multinational investment bank and financial services company, formed in 1998 when Citicorp, the holding company for Citibank, merged with Travelers. Citibank dates to 1812, when it was chartered as City Bank of New York to serve a group of local merchants. In 2009 it merged its Smith Barney brokerage and wealth unit with Morgan Stanley's into a joint venture, and in 2013 it sold its remaining stake to Morgan Stanley. Its businesses cover investment, corporate and commercial banking, sales and trading in the markets, cash management and trade finance for companies, wealth management, and credit cards in the United States.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.26B |
| 2 |
AGN
Allergan plc
AGN
|
+$603M |
| 3 |
Meta Platforms (Facebook)
META
|
+$459M |
| 4 |
Alibaba
BABA
|
+$361M |
| 5 |
Amazon
AMZN
|
+$361M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Russell 1000 Value ETF
IWD
|
+$2.49B |
| 2 |
Qualcomm
QCOM
|
+$424M |
| 3 |
Oracle
ORCL
|
+$369M |
| 4 |
State Street SPDR S&P Aerospace & Defense ETF
XAR
|
+$351M |
| 5 |
RHT
Red Hat
RHT
|
+$311M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 63.01% |
| 2 | Technology | 6.21% |
| 3 | Healthcare | 5.43% |
| 4 | Financials | 5.39% |
| 5 | Consumer Discretionary | 4.54% |
Similar funds
Citigroup's Q3 2019 Portfolio in Review
As of Q3 2019, Citigroup held 8,008 positions worth $126B, up 1.9% from $124B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Citigroup's Q3 2019 filing shows 182 new, 3,096 increased, 3,758 reduced and 270 closed positions. Its largest new stake was Global X Genomics & Biotechnology ETF: 187,500 shares worth $9.38M. The largest sale was iShares Russell 1000 Value ETF, an estimated $2.49B.
By sector, the portfolio is most concentrated in Miscellaneous at 63% of assets, up from 61% a quarter earlier, followed by Technology and Healthcare.
- Citigroup's largest Q3 2019 buy was Global X Genomics & Biotechnology ETF: 187,500 shares worth $9.38M.
- Citigroup added most to State Street SPDR S&P 500 ETF Trust in Q3 2019, an estimated $1.26B increase.
- Citigroup's biggest Q3 2019 reduction was iShares Russell 1000 Value ETF, cutting an estimated $2.49B.
- Citigroup fully exited Red Hat in Q3 2019, selling an estimated $311M.
- Citigroup's ten largest holdings make up 21% of its $126B portfolio in Q3 2019.
- Citigroup opened 182 new positions and closed 270 in Q3 2019.
- Citigroup's portfolio value rose 1.9% quarter-over-quarter to $126B.
Based on Citigroup's 13F filing for Q3 2019, filed 8 Nov 2019.